These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 15767566)
1. Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Weinstein EA; Yano T; Li LS; Avarbock D; Avarbock A; Helm D; McColm AA; Duncan K; Lonsdale JT; Rubin H Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4548-53. PubMed ID: 15767566 [TBL] [Abstract][Full Text] [Related]
2. Type II NADH: menaquinone oxidoreductase of Mycobacterium tuberculosis. Teh JS; Yano T; Rubin H Infect Disord Drug Targets; 2007 Jun; 7(2):169-81. PubMed ID: 17970227 [TBL] [Abstract][Full Text] [Related]
3. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). Yano T; Li LS; Weinstein E; Teh JS; Rubin H J Biol Chem; 2006 Apr; 281(17):11456-63. PubMed ID: 16469750 [TBL] [Abstract][Full Text] [Related]
7. Identification of a small molecule with activity against drug-resistant and persistent tuberculosis. Wang F; Sambandan D; Halder R; Wang J; Batt SM; Weinrick B; Ahmad I; Yang P; Zhang Y; Kim J; Hassani M; Huszar S; Trefzer C; Ma Z; Kaneko T; Mdluli KE; Franzblau S; Chatterjee AK; Johnsson K; Mikusova K; Besra GS; Fütterer K; Robbins SH; Barnes SW; Walker JR; Jacobs WR; Schultz PG Proc Natl Acad Sci U S A; 2013 Jul; 110(27):E2510-7. PubMed ID: 23776209 [TBL] [Abstract][Full Text] [Related]
8. Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery. Sellamuthu S; Singh M; Kumar A; Singh SK Expert Opin Ther Targets; 2017 Jun; 21(6):559-570. PubMed ID: 28472892 [TBL] [Abstract][Full Text] [Related]
9. Pyrrolo[3,4-c]pyridine-1,3(2H)-diones: A Novel Antimycobacterial Class Targeting Mycobacterial Respiration. van der Westhuyzen R; Winks S; Wilson CR; Boyle GA; Gessner RK; Soares de Melo C; Taylor D; de Kock C; Njoroge M; Brunschwig C; Lawrence N; Rao SP; Sirgel F; van Helden P; Seldon R; Moosa A; Warner DF; Arista L; Manjunatha UH; Smith PW; Street LJ; Chibale K J Med Chem; 2015 Dec; 58(23):9371-81. PubMed ID: 26551248 [TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis type II NADH-menaquinone oxidoreductase catalyzes electron transfer through a two-site ping-pong mechanism and has two quinone-binding sites. Yano T; Rahimian M; Aneja KK; Schechter NM; Rubin H; Scott CP Biochemistry; 2014 Feb; 53(7):1179-90. PubMed ID: 24447297 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines. Schurig-Briccio LA; Yano T; Rubin H; Gennis RB Biochim Biophys Acta; 2014 Jul; 1837(7):954-63. PubMed ID: 24709059 [TBL] [Abstract][Full Text] [Related]